ARCHIVES

NCI blocked groups from phase III Iressa studies.

This article is from The Cancer Letter archive.

Vol. 30 No. 18 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

NCAB Grants Three MERIT Awards; Rimer To Leave NCI For Post At UNC

June 21, 2002

Abstracts Of “Most Newsworthy” Papers At AACR Meeting

May 27, 1977

DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off

June 1, 2001

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

In Brief: First Peer-Reviewed Comprehensive Centers Named; Sawaya To Lead Anderson Neurosurgery

October 5, 1990

A Take-Home Message From ASCO 2014: NCI-Funded Clinical Research In Jeopardy,bSociety Focuses on Value of NCTN Groups

June 6, 2014